The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Results of a phase I clinical trial of cetuximab biosimilar (RPH-002).
 
Ali Mudunov
No Relationships to Disclose
 
Marina Lyadova
No Relationships to Disclose
 
Pavel Isaev
No Relationships to Disclose
 
Mikhail Klochikhin
No Relationships to Disclose
 
Igor Belogortsev
No Relationships to Disclose
 
Konstantin Penkov
Consulting or Advisory Role - Nektar
Research Funding - AstraZeneca/MedImmune (Inst); Merck Sharp & Dohme (Inst); Nektar (Inst); Pfizer (Inst); Regeneron (Inst); Roche (Inst)
 
Evgeny Gotovkin
No Relationships to Disclose
 
Anastasia Mochalova
No Relationships to Disclose
 
Rashida Orlova
No Relationships to Disclose
 
Daniil Stroyakovsky
No Relationships to Disclose
 
Alina Gofman
No Relationships to Disclose
 
Vadim Kozlov
No Relationships to Disclose
 
Evgenii Shults
No Relationships to Disclose
 
Victoria Postnikova
No Relationships to Disclose
 
Mikhail Samsonov
Employment - R-Pharm
 
Olga Filon
Employment - R-Pharm
 
Victoria Razzhivina
Employment - R-Pharm
 
Vasilii Ignatiev
Employment - R-Pharm
 
Anna Podolyakina
Employment - R-Pharm
 
Andrey Karpov
Employment - R-Pharm